Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 94
2002 207
2003 234
2004 230
2005 202
2006 178
2007 170
2008 180
2009 163
2010 193
2011 243
2012 276
2013 323
2014 353
2015 471
2016 535
2017 561
2018 511
2019 523
2020 690
2021 665
2022 635
2023 570
2024 338

Text availability

Article attribute

Article type

Publication date

Search Results

7,652 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Virological characteristics of the SARS-CoV-2 JN.1 variant.
Kaku Y, Okumura K, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AA Jr, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Zahradnik J, Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. Epub 2024 Jan 3. Lancet Infect Dis. 2024. PMID: 38184005 No abstract available.
Correction to Lancet Infect Dis 2023; 23: 983.
[No authors listed] [No authors listed] Lancet Infect Dis. 2023 Oct;23(10):e400. doi: 10.1016/S1473-3099(23)00556-X. Epub 2023 Aug 31. Lancet Infect Dis. 2023. PMID: 37660713 No abstract available.
Influenza vaccine shake-up.
The Lancet Infectious Diseases. The Lancet Infectious Diseases. Lancet Infect Dis. 2023 Dec;23(12):1323. doi: 10.1016/S1473-3099(23)00697-7. Lancet Infect Dis. 2023. PMID: 38000878 No abstract available.
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
Yang S, Yu Y, Xu Y, Jian F, Song W, Yisimayi A, Wang P, Wang J, Liu J, Yu L, Niu X, Wang J, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Yang S, et al. Lancet Infect Dis. 2024 Feb;24(2):e70-e72. doi: 10.1016/S1473-3099(23)00744-2. Epub 2023 Dec 15. Lancet Infect Dis. 2024. PMID: 38109919 No abstract available.
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86.
Yang S, Yu Y, Jian F, Song W, Yisimayi A, Chen X, Xu Y, Wang P, Wang J, Yu L, Niu X, Wang J, Xiao T, An R, Wang Y, Gu Q, Shao F, Jin R, Shen Z, Wang Y, Cao Y. Yang S, et al. Lancet Infect Dis. 2023 Nov;23(11):e457-e459. doi: 10.1016/S1473-3099(23)00573-X. Epub 2023 Sep 19. Lancet Infect Dis. 2023. PMID: 37738994 No abstract available.
Correction to Lancet Infect Dis 2023; 23: e397-98.
[No authors listed] [No authors listed] Lancet Infect Dis. 2023 Nov;23(11):e467. doi: 10.1016/S1473-3099(23)00591-1. Epub 2023 Sep 18. Lancet Infect Dis. 2023. PMID: 37734393 No abstract available.
Correction to Lancet Infect Dis 2022; 22: 1293-302.
[No authors listed] [No authors listed] Lancet Infect Dis. 2023 Oct;23(10):e400. doi: 10.1016/S1473-3099(23)00566-2. Epub 2023 Sep 6. Lancet Infect Dis. 2023. PMID: 37683683 No abstract available.
Correction to Lancet Infect Dis 2022; 22: 64-72.
[No authors listed] [No authors listed] Lancet Infect Dis. 2023 Oct;23(10):e400. doi: 10.1016/S1473-3099(23)00561-3. Epub 2023 Aug 31. Lancet Infect Dis. 2023. PMID: 37660707 No abstract available.
7,652 results